1. A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma. Issue 1 (2nd January 2023) Authors: Cortese, Matthew J.; Wei, Wei; Cerdeña, Sebastian; Watkins, Marcus P.; Olson, Marissa; Jodon, Gray; Kaiser, Jeff; Haverkos, Bradley; Hughes, Mitchell E.; Namoglu, Esin; Grover, Natalie S.; Snow, Anson; Orellana-Noia, Victor; Rainey, Magdalena; Sohail, Mohammad; Rudoni, Joslyn; Portell, Craig; Voo... Journal: Leukemia & lymphoma Issue: Volume 64:Issue 1(2023) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020) Authors: Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao... Journal: Lancet Issue: Volume 395:Issue 10232(2020) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Burkitt Lymphoma International Prognostic Index. Issue 10 (1st April 2021) Authors: Olszewski, Adam J.; Jakobsen, Lasse H.; Collins, Graham P.; Cwynarski, Kate; Bachanova, Veronika; Blum, Kristie A.; Boughan, Kirsten M.; Bower, Mark; Dalla Pria, Alessia; Danilov, Alexey; David, Kevin A.; Diefenbach, Catherine; Ellin, Fredrik; Epperla, Narendranath; Farooq, Umar; Feldman, Tatyana... Journal: Journal of clinical oncology Issue: Volume 39:Issue 10(2021) Page Start: 1129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation and associated risk factors for neutropenia with venetoclax and obinutuzumab in the treatment of chronic lymphocytic leukemia. Issue 5 (12th July 2021) Authors: Samuels, Courtney; Abbott, Diana; Niemiec, Sierra; Tobin, Jennifer; Falco, Angela; Halsema, Keri; Kamdar, Manali Journal: Cancer reports Issue: Volume 5:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improved survival with combined modality therapy in the modern era for primary mediastinal B‐cell lymphoma. Issue 5 (4th April 2016) Authors: Jackson, Matthew W.; Rusthoven, Chad G.; Jones, Bernard L.; Kamdar, Manali; Rabinovitch, Rachel Journal: American journal of hematology Issue: Volume 91:Issue 5(2016:May) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Issue 5 (16th April 2019) Authors: Major, Ajay; Jackson, Matthew W.; Smith, Derek E.; Kamdar, Manali; Rabinovitch, Rachel Journal: Leukemia & lymphoma Issue: Volume 60:Issue 5(2019) Page Start: 1234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial. Issue 10343 (18th June 2022) Authors: Kamdar, Manali; Solomon, Scott R; Arnason, Jon; Johnston, Patrick B; Glass, Bertram; Bachanova, Veronika; Ibrahimi, Sami; Mielke, Stephan; Mutsaers, Pim; Hernandez-Ilizaliturri, Francisco; Izutsu, Koji; Morschhauser, Franck; Lunning, Matthew; Maloney, David G; Crotta, Alessandro; Montheard, Sandr... Journal: Lancet Issue: Volume 399:Issue 10343(2022) Page Start: 2294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Risk and subtypes of secondary primary malignancies in diffuse large B‐cell lymphoma survivors change over time based on stage at diagnosis. Issue 1 (11th September 2019) Authors: Major, Ajay; Smith, Derek E.; Ghosh, Debashis; Rabinovitch, Rachel; Kamdar, Manali Journal: Cancer Issue: Volume 126:Issue 1(2020) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secondary CNS involvement of ALK‐negative anaplastic large cell lymphoma. Issue 11 (5th June 2017) Authors: Major, Ajay; Pan, Zenggang; Kamdar, Manali Journal: American journal of hematology Issue: Volume 92:Issue 11(2017:Nov.) Page Start: 1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗